Browsing: weightloss

LLY posted 48% revenue growth and controls 6 in 10 U.S. obesity prescriptions, while NVO cut 12,000 employees and saw gross margins fall to 78%

NEW YORK, Aug 25 (Reuters) – About 14% of employers in the United States have already or plan to drop GLP-1 drugs in 2027, ‌as companies see rising healthcare costs, according to a survey released on Tuesday ‌by the Business Group on Health

From lettuce-wrapped double burger patties to a smoothie with a whopping 45 grams of protein, to a cup of cut-up chicken, protein-forward, light options are beginning to appear on the menus of some popular fast-casual chains across the country in what some companies say is an effort to cater to the rapidly growing number of…

From Nestlé’s Vital Pursuit to GLP-1 menus at Smoothie King, food companies are betting that consumers eating less will demand more protein, fibre and nutrition per bite

Imagine that your doctor tells you there are two medicines that could help you shed a substantial amount of weight. One requires you to swallow a tablet. The other requires you to stick yourself with a needle. For many Americans, the answer seems obvious: give me the pill! But weight-loss pills raise a surprisingly interesting question about…

On August 13, 2026, Novo Nordisk A/S (NYSE:NVO) CEO Mike Doustdar told Reuters that investors are underestimating how much the obesity drug market will fragment as new treatments arrive. He pushed back on the idea that Novo and Eli Lilly and Company (NYSE:LLY) are locked in a zero-sum battle for the same shrinking pool of…

A short-term, intensive weight-loss program before surgery was feasible and produced meaningful weight loss in women with endometrial cancer and excess weight in the randomized ENDO-CARE trial. The intervention was also associated with fewer postoperative complications, although the study was not designed to determine whether weight loss definitively reduces surgical complications. The findings were reported…

August 24, 2026 ByJulie Corliss, Executive Editor, Harvard Heart Letter

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

|| A notice announcing the arrival of Wegovy is posted at a pharmacy in Seoul. This photo is for illustrative purposes. News1